Neuropediatrics 2020; 51(04): 251-258
DOI: 10.1055/s-0040-1708535
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Neonatal Vitamin D Status Is Associated with the Severity of Brain Injury in Neonatal Hypoxic–Ischemic Encephalopathy: A Pilot Study

Elizabeth A. McGinn
1   Division of Neonatology, Department of Pediatrics, University of Nebraska Medical Center, Omaha, Nebraska, United States
,
Andria Powers
2   Department of Radiology, Children's Hospital & Medical Center, Omaha, Nebraska, United States
,
Madeline Galas
3   Munroe-Meyer Institute, University of Nebraska Medical Center, Omaha, Nebraska, United States
,
Elizabeth Lyden
4   Department of Biostatistics, University of Nebraska Medical Center, Omaha, Nebraska, United States
,
Eric S. Peeples
1   Division of Neonatology, Department of Pediatrics, University of Nebraska Medical Center, Omaha, Nebraska, United States
› Author Affiliations
Further Information

Publication History

22 June 2019

16 January 2020

Publication Date:
16 March 2020 (online)

Abstract

Objective The primary aim of this study was to evaluate the association between 25-hydroxyvitamin D (25OHD) concentration at birth and the short-term outcomes in neonatal hypoxic–ischemic encephalopathy (HIE). Our secondary aim was to evaluate the effect of postnatal vitamin D supplementation on outcomes in the perinatal period after hypoxic injury.

Study Design This retrospective cohort study included all infants ≥35 weeks gestation admitted to a regional level IV neonatal intensive care unit and diagnosed with moderate or severe HIE. Spearman correlation coefficients were used to evaluate associations between clinical outcomes including standardized brain magnetic resonance imaging (MRI) scores and either 25OHD concentrations in the first 48 hours of life or total vitamin D supplementation.

Result A total of 43 infants met inclusion criteria; 22 had 25OHD concentrations drawn within the first 48 hours. There was a significant inverse association between 25OHD concentration and brain injury on MRI (p = 0.017). There was a trend toward decreased ventilator days in infants receiving higher doses of vitamin D in the first week of life (p = 0.062), but there was no association between vitamin D dosing and MRI injury.

Conclusion These results support an association between lower vitamin-D levels and early adverse outcomes in HIE, including radiographic severity of brain injury.

 
  • References

  • 1 Holick MF. The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord 2017; 18 (02) 153-165
  • 2 Saraf R, Morton SM, Camargo Jr CA, Grant CC. Global summary of maternal and newborn vitamin D status - a systematic review. Matern Child Nutr 2016; 12 (04) 647-668
  • 3 Eyles D, Brown J, Mackay-Sim A, McGrath J, Feron F. Vitamin D3 and brain development. Neuroscience 2003; 118 (03) 641-653
  • 4 Harms LR, Burne TH, Eyles DW, McGrath JJ. Vitamin D and the brain. Best Pract Res Clin Endocrinol Metab 2011; 25 (04) 657-669
  • 5 Anjum I, Jaffery SS, Fayyaz M, Samoo Z, Anjum S. The role of vitamin D in brain health: a mini literature review. Cureus 2018; 10 (07) e2960
  • 6 Douglas-Escobar M, Weiss MD. Hypoxic-ischemic encephalopathy: a review for the clinician. JAMA Pediatr 2015; 169 (04) 397-403
  • 7 van Laerhoven H, de Haan TR, Offringa M, Post B, van der Lee JH. Prognostic tests in term neonates with hypoxic-ischemic encephalopathy: a systematic review. Pediatrics 2013; 131 (01) 88-98
  • 8 Calvert JW, Zhang JH. Pathophysiology of an hypoxic-ischemic insult during the perinatal period. Neurol Res 2005; 27 (03) 246-260
  • 9 Lowe DW, Hollis BW, Wagner CL. , et al. Vitamin D insufficiency in neonatal hypoxic-ischemic encephalopathy. Pediatr Res 2017; 82 (01) 55-62
  • 10 Mutlu M, Sarıaydın M, Aslan Y. , et al. Status of vitamin D, antioxidant enzymes, and antioxidant substances in neonates with neonatal hypoxic-ischemic encephalopathy. J Matern Fetal Neonatal Med 2016; 29 (14) 2259-2263
  • 11 Ikeda U, Wakita D, Ohkuri T. , et al. 1α,25-Dihydroxyvitamin D3 and all-trans retinoic acid synergistically inhibit the differentiation and expansion of Th17 cells. Immunol Lett 2010; 134 (01) 7-16
  • 12 Waisman A, Hauptmann J, Regen T. The role of IL-17 in CNS diseases. Acta Neuropathol 2015; 129 (05) 625-637
  • 13 White JH. Regulation of intracrine production of 1,25-dihydroxyvitamin D and its role in innate immune defense against infection. Arch Biochem Biophys 2012; 523 (01) 58-63
  • 14 Holick MF, Binkley NC, Bischoff-Ferrari HA. , et al; Endocrine Society Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96 (07) 1911-1930
  • 15 Turpeinen U, Hohenthal U, Stenman UH. Determination of 25-hydroxyvitamin D in serum by HPLC and immunoassay. Clin Chem 2003; 49 (09) 1521-1524
  • 16 Maunsell Z, Wright DJ, Rainbow SJ. Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. Clin Chem 2005; 51 (09) 1683-1690
  • 17 Saenger AK, Laha TJ, Bremner DE, Sadrzadeh SM. Quantification of serum 25-hydroxyvitamin D(2) and D(3) using HPLC-tandem mass spectrometry and examination of reference intervals for diagnosis of vitamin D deficiency. Am J Clin Pathol 2006; 125 (06) 914-920
  • 18 Le Goff C, Cavalier E, Souberbielle JC, González-Antuña A, Delvin E. Measurement of circulating 25-hydroxyvitamin D: a historical review. Pract Lab Med 2015; 2: 1-14
  • 19 Chen H, McCoy LF, Schleicher RL, Pfeiffer CM. Measurement of 25-hydroxyvitamin D3 (25OHD3) and 25-hydroxyvitamin D2 (25OHD2) in human serum using liquid chromatography-tandem mass spectrometry and its comparison to a radioimmunoassay method. Clin Chim Acta 2008; 391 (1-2): 6-12
  • 20 Ooms N, van Daal H, Beijers AM, Gerrits GP, Semmekrot BA, van den Ouweland JM. Time-course analysis of 3-epi-25-hydroxyvitamin D3 shows markedly elevated levels in early life, particularly from vitamin D supplementation in preterm infants. Pediatr Res 2016; 79 (04) 647-653
  • 21 Higgins V, Truong D, White-Al Habeeb NMA, Fung AWS, Hoffman B, Adeli K. Pediatric reference intervals for 1,25-dihydroxyvitamin D using the DiaSorin LIAISON XL assay in the healthy CALIPER cohort. Clin Chem Lab Med 2018; 56 (06) 964-972
  • 22 Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Arch Neurol 1976; 33 (10) 696-705
  • 23 Mohammad A, Jindal I, Khilfeh M. , et al. Prevalence of vitamin D deficiency and the requirement of vitamin D in VLBW infants. Pediatrics 2018 142. (01):
  • 24 við Streym S, Højskov CS, Møller UK. , et al. Vitamin D content in human breast milk: a 9-mo follow-up study. Am J Clin Nutr 2016; 103 (01) 107-114
  • 25 Weeke LC, Groenendaal F, Mudigonda K. , et al. A novel magnetic resonance imaging score predicts neurodevelopmental outcome after perinatal asphyxia and therapeutic hypothermia. J Pediatr 2018; 192: 33-40.e2
  • 26 Ment LR, Bada HS, Barnes P. , et al. Practice parameter: neuroimaging of the neonate: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2002; 58 (12) 1726-1738
  • 27 Bednarek N, Mathur A, Inder T, Wilkinson J, Neil J, Shimony J. Impact of therapeutic hypothermia on MRI diffusion changes in neonatal encephalopathy. Neurology 2012; 78 (18) 1420-1427
  • 28 Li J, Funato M, Tamai H. , et al. Predictors of neurological outcome in cooled neonates. Pediatr Int 2013; 55 (02) 169-176
  • 29 Brewer LD, Thibault V, Chen KC, Langub MC, Landfield PW, Porter NM. Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J Neurosci 2001; 21 (01) 98-108
  • 30 Wang JY, Wu JN, Cherng TL. , et al. Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats. Brain Res 2001; 904 (01) 67-75
  • 31 Chen KB, Lin AM, Chiu TH. Systemic vitamin D3 attenuated oxidative injuries in the locus coeruleus of rat brain. Ann N Y Acad Sci 2003; 993: 313-324 , discussion 345–349
  • 32 Obradovic D, Gronemeyer H, Lutz B, Rein T. Cross-talk of vitamin D and glucocorticoids in hippocampal cells. J Neurochem 2006; 96 (02) 500-509
  • 33 Fee SC, Malee K, Deddish R, Minogue JP, Socol ML. Severe acidosis and subsequent neurologic status. Am J Obstet Gynecol 1990; 162 (03) 802-806
  • 34 Goldaber KG, Gilstrap III LC, Leveno KJ, Dax JS, McIntire DD. Pathologic fetal acidemia. Obstet Gynecol 1991; 78 (06) 1103-1107
  • 35 Lavrijsen SW, Uiterwaal CS, Stigter RH, de Vries LS, Visser GH, Groenendaal F. Severe umbilical cord acidemia and neurological outcome in preterm and full-term neonates. Biol Neonate 2005; 88 (01) 27-34
  • 36 Yu RQ, Chen DZ, Hao XQ, Jiang SH, Fang GD, Zhou Q. Relationship between serum 25(OH)D levels at birth and respiratory distress syndrome in preterm infants [in Chinese]. Zhongguo Dang Dai Er Ke Za Zhi 2017; 19 (11) 1134-1137
  • 37 Yu RQ, Chen DZ, Zhou Q, Wang M, Mei YZ, Jiang SY. Association between serum 25(OH)D levels at birth and bronchopulmonary dysplasia in preterm infants [in Chinese]. Zhongguo Dang Dai Er Ke Za Zhi 2017; 19 (10) 1051-1055
  • 38 Hibbs AM, Ross K, Kerns LA. , et al. Effect of vitamin D Supplementation on recurrent wheezing in black infants who were born preterm: the D-Wheeze randomized clinical trial. JAMA 2018; 319 (20) 2086-2094
  • 39 Lykkedegn S, Sorensen GL, Beck-Nielsen SS, Christesen HT. The impact of vitamin D on fetal and neonatal lung maturation. A systematic review. Am J Physiol Lung Cell Mol Physiol 2015; 308 (07) L587-L602
  • 40 Hagag AA, El Frargy MS, Abd El-Latif AE. Vitamin D as an adjuvant therapy in neonatal hypoxia: is it beneficial?. Endocr Metab Immune Disord Drug Targets 2019; 19 (03) 341-348